Mary Mader is currently the Vice President of Molecular Innovation at Indiana Biosciences Research Institute and a member of the Expert Scientific Advisory Committee at Medicines for Malaria Venture. Previously, Mary held roles at Relay Therapeutics as the Vice President of Chemistry, at Eli Lilly and Company in various research and advisory positions, and as a Visiting Scientist at Bayer Health Care. Mary also served as a Professor at Grinnell College and holds degrees from the University of California, Berkeley, the University of Notre Dame, and The Ohio State University.
February, 2022 - present